The past weekend rounded up the recent trend of brutally high-volume selling on Chinese bitcoin exchanges. On 28th September, bitcoin dropped to a new five-month low of $372.35. The previous record low for Coindesk’s Bitcoin Price Index (BPI), is the six-month bottom reached on 10th April at $360.84. Meanwhile, trading volumes touched historical highs for…
Halozyme Therapeutics, Inc (HALO) announced that the FDA has lifted the clinical hold from a phase Ib/II study (Study S1313). The study is evaluating PEGPH20 (PEGylated recombinant human hyaluronidase) in combination with a modified FOLFIRINOX chemotherapy (mFOLFIRINOX) in patients suffering from metastatic pancreatic adenocarcinoma. The Study S1313, which is being sponsored and conducted by SWOG…
After five years of planning, Microsoft to open shop, literally, at 677 Fifth Avenue. While Microsoft Corporation (NASDAQ MSFT) has been working its way into retail to push the Xbox and mobile products for years, the company is now ready to go big. “As our first flagship store, it will serve as the centerpiece of…
Google Inc (NASDAQ GOOG)’s forthcoming Nexus 6 smartphone has been subject of a lot of rumours in the past few weeks. Some leaks claim that the search engine giant will drop the name Nexus 6 in favor of Nexus X. Others indicate that Google will unveil the Nexus 6 quietly rather than holding a mega-event…
Facebook Inc (NASDAQ FB) has enhanced Atlas ad server that will be launched fully this week, and has been dubbed as “marketing nirvana” by one of the digital advertising CEO, according to Ad Week. The social networking site is now opening its knowledge base of its billion users for all marketers, which according to experts…
Amgen (AMGN) announced that it has submitted a Biologics License Application (BLA) to the FDA for its oncology candidate, blinatumomab. The company is looking to get the candidate approved for the treatment of adults suffering from Philadelphia-negative (Ph-) relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL). The BLA includes positive data from a phase II study which…
